A novel fully human anti-NCL immunoRNase for triple-negative breast cancer therapy

Breast cancer is the most common cancer in women worldwide. A new promising anti-cancer therapy involves the use of monoclonal antibodies specific for target tumor-associated antigens (TAAs). A TAA of interest for immunotherapy of Triple Negative Breast Cancer (TNBC) is nucleolin (NCL), a multifunct...

Descripción completa

Detalles Bibliográficos
Autores principales: D'Avino, Chiara, Palmieri, Dario, Braddom, Ashley, Zanesi, Nicola, James, Cindy, Cole, Sara, Salvatore, Francesco, Croce, Carlo M., De Lorenzo, Claudia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5349967/
https://www.ncbi.nlm.nih.gov/pubmed/27894092
http://dx.doi.org/10.18632/oncotarget.13522

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5349967/
https://www.ncbi.nlm.nih.gov/pubmed/27894092
http://dx.doi.org/10.18632/oncotarget.13522

Ejemplares similares